A Common Trigger in Neurodegenerative and Metabolic Non-Communicable Diseases"

Paola Fortini,Barbara Pascucci

DOI: https://doi.org/10.3390/ijms25074004

IF: 5.6

2024-04-04

International Journal of Molecular Sciences

Abstract:Non-communicable diseases (NCDs) are non-infectious and non-transmissible chronic disorders [...]

biochemistry & molecular biology,chemistry, multidisciplinary

What problem does this paper attempt to address?

Vascular Function in Chronic Non-Communicable Diseases 2.0

Annalisa Noce,Manfredi Tesauro

DOI: https://doi.org/10.3390/biomedicines12122761

IF: 4.757

2024-12-05

Biomedicines

Abstract:Chronic degenerative non-communicable diseases (CDNCDs) represent the main causes of mortality and morbidity worldwide [...]

biochemistry & molecular biology,medicine, research & experimental,pharmacology & pharmacy
Viral and Inflammatory Triggers of Neurodegenerative Diseases

Michela Deleidi,Ole Isacson

DOI: https://doi.org/10.1126/scitranslmed.3003492

IF: 17.1

2012-02-15

Science Translational Medicine

Abstract:Immune pathways and cytokines induced by viral infections can render neurons vulnerable to subsequent degeneration and may serve as therapeutic targets for neuroprotection.

cell biology,medicine, research & experimental
Pathogenic or Therapeutic: The Mediating Role of Gut Microbiota in Non-Communicable Diseases

Fan Bu,Xingran Yao,Zhihua Lu,Xiaomin Yuan,Chen Chen,Lu Li,Youran Li,Feng Jiang,Lei Zhu,Guoping Shi,Yugen Chen

DOI: https://doi.org/10.3389/fcimb.2022.906349

IF: 6.073

2022-07-08

Frontiers in Cellular and Infection Microbiology

Abstract:Noncommunicable diseases (NCDs) lead to 41 million deaths every year and account for 71% of all deaths worldwide. Increasing evidence indicates that gut microbiota disorders are closely linked to the occurrence and development of diseases. The gut microbiota, as a potential transmission medium, could play a key role in the transmission and treatment of diseases. The gut microbiota makes noncommunicable diseases communicable. New methods of the prevention and treatment of these diseases could be further explored through the gut microbiota.

immunology,microbiology
Diet, Nutrition and Chronic Degenerative Diseases

Laura Di Renzo,Paola Gualtieri,Antonino De Lorenzo

DOI: https://doi.org/10.3390/nu13041372

IF: 5.9

2021-04-20

Nutrients

Abstract:Chronic degenerative diseases (CDDs), represented mainly by obesity, cardiovascular disease (CVD), diabetes, chronic kidney disease (CKD), inflammatory bowel diseases, osteoporosis, sarcopenia, neurodegenerative diseases such as Huntington’s disease (HD), rheumatoid arthritis (RA), chronic respiratory diseases, and many cancers, have been, up to now, the most frequent causes of prolonged disability and death worldwide [...]

nutrition & dietetics
Infectious Agents and Neurodegeneration

Giovanna De Chiara,Maria Elena Marcocci,Rossella Sgarbanti,Livia Civitelli,Cristian Ripoli,Roberto Piacentini,Enrico Garaci,Claudio Grassi,Anna Teresa Palamara

DOI: https://doi.org/10.1007/s12035-012-8320-7

IF: 5.682

2012-08-17

Molecular Neurobiology

Abstract:A growing body of epidemiologic and experimental data point to chronic bacterial and viral infections as possible risk factors for neurodegenerative diseases, including Alzheimer’s disease, Parkinson’s disease and amyotrophic lateral sclerosis. Infections of the central nervous system, especially those characterized by a chronic progressive course, may produce multiple damage in infected and neighbouring cells. The activation of inflammatory processes and host immune responses cause chronic damage resulting in alterations of neuronal function and viability, but different pathogens can also directly trigger neurotoxic pathways. Indeed, viral and microbial agents have been reported to produce molecular hallmarks of neurodegeneration, such as the production and deposit of misfolded protein aggregates, oxidative stress, deficient autophagic processes, synaptopathies and neuronal death. These effects may act in synergy with other recognized risk factors, such as aging, concomitant metabolic diseases and the host’s specific genetic signature. This review will focus on the contribution given to neurodegeneration by herpes simplex type-1, human immunodeficiency and influenza viruses, and by Chlamydia pneumoniae.

neurosciences
Pathophysiology of neurodegenerative diseases: An interplay among axonal transport failure, oxidative stress, and inflammation?

Giuseppina Tesco,Selene Lomoio

DOI: https://doi.org/10.1016/j.smim.2022.101628

IF: 10.671

2022-01-01

Seminars in Immunology

Abstract:Neurodegenerative diseases (NDs) are heterogeneous neurological disorders characterized by a progressive loss of selected neuronal populations. A significant risk factor for most NDs is aging. Considering the constant increase in life expectancy, NDs represent a global public health burden. Axonal transport (AT) is a central cellular process underlying the generation and maintenance of neuronal architecture and connectivity. Deficits in AT appear to be a common thread for most, if not all, NDs. Neuroinflammation has been notoriously difficult to define in relation to NDs. Inflammation is a complex multifactorial process in the CNS, which varies depending on the disease stage. Several lines of evidence suggest that AT defect, axonopathy and neuroinflammation are tightly interlaced. However, whether these impairments play a causative role in NDs or are merely a downstream effect of neuronal degeneration remains unsettled. We still lack reliable information on the temporal relationship between these pathogenic mechanisms, although several findings suggest that they may occur early during ND pathophysiology. This article will review the latest evidence emerging on whether the interplay between AT perturbations and some aspects of CNS inflammation can participate in ND etiology, analyze their potential as therapeutic targets, and the urge to identify early surrogate biomarkers.

immunology
Sex and Gender Differences in Neurodegenerative Diseases: Challenges for Therapeutic Opportunities

Annalisa Bianco,Ylenia Antonacci,Maria Liguori

DOI: https://doi.org/10.3390/ijms24076354

2023-03-28

Abstract:The term "neurodegenerative diseases" (NDs) identifies a group of heterogeneous diseases characterized by progressive loss of selectively vulnerable populations of neurons, which progressively deteriorates over time, leading to neuronal dysfunction. Protein aggregation and neuronal loss have been considered the most characteristic hallmarks of NDs, but growing evidence confirms that significant dysregulation of innate immune pathways plays a crucial role as well. NDs vary from multiple sclerosis, in which the autoimmune inflammatory component is predominant, to more "classical" NDs, such as Parkinson's disease, Alzheimer's disease, amyotrophic lateral sclerosis, and spinal muscular atrophy. Of interest, many of the clinical differences reported in NDs seem to be closely linked to sex, which may be justified by the significant changes in immune mechanisms between affected females and males. In this review, we examined some of the most studied NDs by looking at their pathogenic and phenotypical features to highlight sex-related discrepancies, if any, with particular interest in the individuals' responses to treatment. We believe that pointing out these differences in clinical practice may help achieve more successful precision and personalized care.
Oxidative Stress and Inflammation as Targets for Novel Preventive and Therapeutic Approaches in Non-Communicable Diseases III

Chiara Nediani,Jessica Ruzzolini,Monica Dinu

DOI: https://doi.org/10.3390/antiox13111404

IF: 7.675

2024-11-23

Antioxidants

Abstract:Non-communicable diseases (NCDs), including cardiovascular diseases, diabetes, and neurodegenerative disorders, pose a significant global health challenge [...]

biochemistry & molecular biology,chemistry, medicinal,food science & technology
Contribution of CNS and extra-CNS infections to neurodegeneration: a narrative review

Pinja Kettunen,Jari Koistinaho,Taisia Rolova

DOI: https://doi.org/10.1186/s12974-024-03139-y

IF: 9.3

2024-06-09

Journal of Neuroinflammation

Abstract:Central nervous system infections have been suggested as a possible cause for neurodegenerative diseases, particularly sporadic cases. They trigger neuroinflammation which is considered integrally involved in neurodegenerative processes. In this review, we will look at data linking a variety of viral, bacterial, fungal, and protozoan infections to Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis, multiple sclerosis and unspecified dementia. This narrative review aims to bring together a broad range of data currently supporting the involvement of central nervous system infections in the development of neurodegenerative diseases. The idea that no single pathogen or pathogen group is responsible for neurodegenerative diseases will be discussed. Instead, we suggest that a wide range of susceptibility factors may make individuals differentially vulnerable to different infectious pathogens and subsequent pathologies.

immunology,neurosciences
A shared framework for the common mental disorders and Non-Communicable Disease: key considerations for disease prevention and control

Adrienne O'Neil,Felice N Jacka,Shae E Quirk,Fiona Cocker,C Barr Taylor,Brian Oldenburg,Michael Berk

DOI: https://doi.org/10.1186/s12888-015-0394-0

IF: 4.144

2015-02-05

BMC Psychiatry

Abstract:Background: Historically, the focus of Non Communicable Disease (NCD) prevention and control has been cardiovascular disease (CVD), type 2 diabetes mellitus (T2DM), cancer and chronic respiratory diseases. Collectively, these account for more deaths than any other NCDs. Despite recent calls to include the common mental disorders (CMDs) of depression and anxiety under the NCD umbrella, prevention and control of these CMDs remain largely separate and independent. Discussion: In order to address this gap, we apply a framework recently proposed by the Centers for Disease Control with three overarching objectives: (1) to obtain better scientific information through surveillance, epidemiology, and prevention research; (2) to disseminate this information to appropriate audiences through communication and education; and (3) to translate this information into action through programs, policies, and systems. We conclude that a shared framework of this type is warranted, but also identify opportunities within each objective to advance this agenda and consider the potential benefits of this approach that may exist beyond the health care system.
Exploring the “Multiple-Hit Hypothesis” of Neurodegenerative Disease: Bacterial Infection Comes Up to Bat

Kristin L. Patrick,Samantha L. Bell,Chi G. Weindel,Robert O. Watson

DOI: https://doi.org/10.3389/fcimb.2019.00138

IF: 6.073

2019-05-28

Frontiers in Cellular and Infection Microbiology

Abstract:Despite major strides in personalized genomics, it remains poorly understood why neurodegenerative diseases occur in only a fraction of individuals with a genetic predisposition and conversely, why individuals with no genetic risk of a disorder develop one. Chronic diseases like Alzheimer's, Parkinson's, and Multiple sclerosis are speculated to result from a combination of genetic and environmental factors, a concept commonly referred to as the "multiple hit hypothesis." A number of bacterial infections have been linked to increased risk of neurodegeneration, and in some cases, clearance of bacterial pathogens has been correlated with amelioration of central nervous system (CNS) deficits. Additionally, mutations in several genes known to contribute to CNS disorders like Parkinson's Disease have repeatedly been implicated in susceptibility to intracellular bacterial infection. Recent data has begun to demonstrate roles for these genes (<i>PARK2, PINK1</i>, and <i>LRRK2</i>) in modulating innate immune outcomes, suggesting that immune dysregulation may play an even more important role in neurodegeneration than previously appreciated. This review will broadly explore the connections between bacterial infection, immune dysregulation, and CNS disorders. Understanding this interplay and how bacterial pathogenesis contributes to the "multiple-hit hypothesis" of neurodegeneration will be crucial to develop therapeutics to effectively treat both neurodegeneration and infection.

immunology,microbiology
New Insights in Neurodegenerative Diseases

Adithya K. Anilkumar,Puneet Vij,Samantha Lopez,Sophia M. Leslie,Kyle Doxtater,Mohammad Moshahid Khan,Murali M. Yallapu,Subhash C. Chauhan,Gladys E. Maestre,Manish K. Tripathi

DOI: https://doi.org/10.3390/ijms25042268

IF: 5.6

2024-02-14

International Journal of Molecular Sciences

Abstract:Neurodegenerative diseases (NDDs), including Alzheimer's disease (AD), Parkinson's disease (PD), and amyotrophic lateral sclerosis (ALS), are gradually becoming a burden to society. The adverse effects and mortality/morbidity rates associated with these NDDs are a cause of many healthcare concerns. The pathologic alterations of NDDs are related to mitochondrial dysfunction, oxidative stress, and inflammation, which further stimulate the progression of NDDs. Recently, long non-coding RNAs (lncRNAs) have attracted ample attention as critical mediators in the pathology of NDDs. However, there is a significant gap in understanding the biological function, molecular mechanisms, and potential importance of lncRNAs in NDDs. This review documents the current research on lncRNAs and their implications in NDDs. We further summarize the potential implication of lncRNAs to serve as novel therapeutic targets and biomarkers for patients with NDDs.

biochemistry & molecular biology,chemistry, multidisciplinary
Interplay among gut microbiota, intestinal mucosal barrier and enteric neuro-immune system: a common path to neurodegenerative diseases?

Carolina Pellegrini,Luca Antonioli,Rocchina Colucci,Corrado Blandizzi,Matteo Fornai

DOI: https://doi.org/10.1007/s00401-018-1856-5

IF: 15.887

2018-05-24

Acta Neuropathologica

Abstract:Neurological diseases, such as Parkinson’s disease, Alzheimer’s disease, amyotrophic lateral sclerosis (ALS) and multiple sclerosis, are often associated with functional gastrointestinal disorders. These gastrointestinal disturbances may occur at all stages of the neurodegenerative diseases, to such an extent that they are now considered an integral part of their clinical picture. Several lines of evidence support the contention that, in central neurodegenerative diseases, changes in gut microbiota and enteric neuro-immune system alterations could contribute to gastrointesinal dysfunctions as well as initiation and upward spreading of the neurologic disorder. The present review has been intended to provide a comprehensive overview of the available knowledge on the role played by enteric microbiota, mucosal immune system and enteric nervous system, considered as an integrated network, in the pathophysiology of the main neurological diseases known to be associated with intestinal disturbances. In addition, based on current human and pre-clinical evidence, our intent was to critically discuss whether changes in the dynamic interplay between gut microbiota, intestinal epithelial barrier and enteric neuro-immune system are a consequence of the central neurodegeneration or might represent the starting point of the neurodegenerative process. Special attention has been paid also to discuss whether alterations of the enteric bacterial-neuro-immune network could represent a common path driving the onset of the main neurodegenerative diseases, even though each disease displays its own distinct clinical features.

pathology,neurosciences,clinical neurology
Overlapping Neuroimmune Mechanisms and Therapeutic Targets in Neurodegenerative Disorders

Fabiola De Marchi,Ivana Munitic,Lea Vidatic,Eliša Papić,Valentino Rački,Jerneja Nimac,Igor Jurak,Gabriela Novotni,Boris Rogelj,Vladimira Vuletic,Rajka M Liscic,Jason R Cannon,Emanuele Buratti,Letizia Mazzini,Silva Hecimovic

DOI: https://doi.org/10.3390/biomedicines11102793

IF: 4.757

2023-10-14

Biomedicines

Abstract:Many potential immune therapeutic targets are similarly affected in adult-onset neurodegenerative diseases, such as Alzheimer's (AD) disease, Parkinson's disease (PD), amyotrophic lateral sclerosis (ALS), and frontotemporal dementia (FTD), as well as in a seemingly distinct Niemann-Pick type C disease with primarily juvenile onset. This strongly argues for an overlap in pathogenic mechanisms. The commonly researched immune targets include various immune cell subsets, such as microglia, peripheral macrophages, and regulatory T cells (Tregs); the complement system; and other soluble factors. In this review, we compare these neurodegenerative diseases from a clinical point of view and highlight common pathways and mechanisms of protein aggregation, neurodegeneration, and/or neuroinflammation that could potentially lead to shared treatment strategies for overlapping immune dysfunctions in these diseases. These approaches include but are not limited to immunisation, complement cascade blockade, microbiome regulation, inhibition of signal transduction, Treg boosting, and stem cell transplantation.
Special Issue: "Neurodegenerative Diseases: Recent Advances and Future Perspectives"

López-Cuenca,Hoz

DOI: https://doi.org/10.3390/biomedicines12051080

IF: 4.757

2024-05-14

Biomedicines

Abstract:Neurodegenerative diseases include a heterogeneous group of conditions that pose a growing challenge to public health and the scientific community [1] [...]

biochemistry & molecular biology,medicine, research & experimental,pharmacology & pharmacy
Small Non-coding RNAs: New Class of Biomarkers and Potential Therapeutic Targets in Neurodegenerative Disease

Callum N. Watson,Antonio Belli,Valentina Di Pietro

DOI: https://doi.org/10.3389/fgene.2019.00364

IF: 3.7

2019-04-26

Frontiers in Genetics

Abstract:Neurodegenerative diseases (NDs) are becoming increasingly prevalent in the world, with an aging population. In the last few decades, due to the devastating nature of these diseases, the research of biomarkers has become crucial to enable adequate treatments and to monitor the progress of disease. Currently, gene mutations, CSF and blood protein markers together with the neuroimaging techniques are the most used diagnostic approaches. However, despite the efforts in the research, conflicting data still exist, highlighting the need to explore new classes of biomarkers, particularly at early stages. Small non-coding RNAs (MicroRNA, Small nuclear RNA, Small nucleolar RNA, tRNA derived small RNA and Piwi-interacting RNA) can be considered a "relatively" new class of molecule that have already proved to be differentially regulated in many NDs, hence they represent a new potential class of biomarkers to be explored. In addition, understanding their involvement in disease development could depict the underlying pathogenesis of particular NDs, so novel treatment methods that act earlier in disease progression can be developed. This review aims to describe the involvement of small non-coding RNAs as biomarkers of NDs and their potential role in future clinical applications.

genetics & heredity
Target- and mechanism-based therapeutics for neurodegenerative diseases: strength in numbers

Paul C Trippier,Kristin Jansen Labby,Dustin D Hawker,Jan J Mataka,Richard B Silverman

DOI: https://doi.org/10.1021/jm3015926

2013-04-25

Abstract:The development of new therapeutics for the treatment of neurodegenerative pathophysiologies currently stands at a crossroads. This presents an opportunity to transition future drug discovery efforts to target disease modification, an area in which much still remains unknown. In this Perspective we examine recent progress in the areas of neurodegenerative drug discovery, focusing on some of the most common targets and mechanisms: N-methyl-d-aspartic acid (NMDA) receptors, voltage gated calcium channels (VGCCs), neuronal nitric oxide synthase (nNOS), oxidative stress from reactive oxygen species, and protein aggregation. These represent the key players identified in neurodegeneration and are part of a complex, intertwined signaling cascade. The synergistic delivery of two or more compounds directed against these targets, along with the design of small molecules with multiple modes of action, should be explored in pursuit of more effective clinical treatments for neurodegenerative diseases.
Exploring the Exposome Spectrum: Unveiling Endogenous and Exogenous Factors in Non-Communicable Chronic Diseases

Laura Di Renzo,Paola Gualtieri,Giulia Frank,Rossella Cianci,Mario Caldarelli,Giulia Leggeri,Glauco Raffaelli,Erica Pizzocaro,Michela Cirillo,Antonino De Lorenzo

DOI: https://doi.org/10.3390/diseases12080176

2024-08-02

Diseases

Abstract:The exposome encompasses all endogenous and exogenous exposure individuals encounter throughout their lives, including biological, chemical, physical, psychological, relational, and socioeconomic factors. It examines the duration and intensity of these types of exposure and their complex interactions over time. This interdisciplinary approach involves various scientific disciplines, particularly toxicology, to understand the long-term effects of toxic exposure on health. Factors like air pollution, racial background, and socioeconomic status significantly contribute to diseases such as metabolic, cardiovascular, neurodegenerative diseases, infertility, and cancer. Advanced analytical methods measure contaminants in biofluids, food, air, water, and soil, but often overlook the cumulative risk of multiple chemicals. An exposome analysis necessitates sophisticated tools and methodologies to understand health interactions and integrate findings into precision medicine for better disease diagnosis and treatment. Chronic exposure to environmental and biological stimuli can lead to persistent low-grade inflammation, which is a key factor in chronic non-communicable diseases (NCDs), such as obesity, cardiometabolic disorders, cancer, respiratory diseases, autoimmune conditions, and depression. These NCDs are influenced by smoking, unhealthy diets, physical inactivity, and alcohol abuse, all shaped by genetic, environmental, and social factors. Dietary patterns, especially ultra-processed foods, can exacerbate inflammation and alter gut microbiota. This study investigates the exposome's role in the prevention, development, and progression of NCDs, focusing on endogenous and exogenous factors.
Investigating the Interplay between Cardiovascular and Neurodegenerative Disease

Jason Patrick Cousineau,Aimee Maria Dawe,Melanie Alpaugh

DOI: https://doi.org/10.3390/biology13100764

2024-09-27

Biology

Abstract:Neurological diseases, including neurodegenerative diseases (NDDs), are the primary cause of disability worldwide and the second leading cause of death. The chronic nature of these conditions and the lack of disease-modifying therapies highlight the urgent need for developing effective therapies. To accomplish this, effective models of NDDs are required to increase our understanding of underlying pathophysiology and for evaluating treatment efficacy. Traditionally, models of NDDs have focused on the central nervous system (CNS). However, evidence points to a relationship between systemic factors and the development of NDDs. Cardiovascular disease and related risk factors have been shown to modify the cerebral vasculature and the risk of developing Alzheimer's disease. These findings, combined with reports of changes to vascular density and blood–brain barrier integrity in other NDDs, such as Huntington's disease and Parkinson's disease, suggest that cardiovascular health may be predictive of brain function. To evaluate this, we explore evidence for disruptions to the circulatory system in murine models of NDDs, evidence of disruptions to the CNS in cardiovascular disease models and summarize models combining cardiovascular disruption with models of NDDs. In this study, we aim to increase our understanding of cardiovascular disease and neurodegeneration interactions across multiple disease states and evaluate the utility of combining model systems.

biology
The path to biomarker-based diagnostic criteria for the spectrum of neurodegenerative diseases

Filippo Baldacci,Sonia Mazzucchi,Alessandra Della Vecchia,Linda Giampietri,Nicola Giannini,Maya Koronyo-Hamaoui,Roberto Ceravolo,Gabriele Siciliano,Ubaldo Bonuccelli,Fanny M. Elahi,Andrea Vergallo,Simone Lista,Filippo Sean Giorgi,Harald Hampel

DOI: https://doi.org/10.1080/14737159.2020.1731306

2020-02-27

Expert Review of Molecular Diagnostics

Abstract:Introduction: The postmortem examination still represents the reference standard for detecting the pathological nature of chronic neurodegenerative diseases (NDD). This approach displays intrinsic conceptual limitations since NDD represent a dynamic spectrum of partially overlapping phenotypes, shared pathomechanistic alterations that often give rise to mixed pathologies.Areas covered: We scrutinized the international clinical diagnostic criteria of NDD and the literature to provide a roadmap toward a biomarker-based classification of the NDD spectrum. A few pathophysiological biomarkers have been established for NDD. These are time-consuming, invasive, and not suitable for preclinical detection. Candidate screening biomarkers are gaining momentum. Blood neurofilament light-chain represents a robust first-line tool to detect neurodegeneration tout court and serum progranulin helps detect genetic frontotemporal dementia. Ultrasensitive assays and retinal scans may identify Aβ pathology early, in blood and the eye, respectively. Ultrasound also represents a minimally invasive option to investigate the substantia nigra. Protein misfolding amplification assays may accurately detect α-synuclein in biofluids.Expert opinion: Data-driven strategies using quantitative rather than categorical variables may be more reliable for quantification of contributions from pathophysiological mechanisms and their spatial-temporal evolution. A systems biology approach is suitable to untangle the dynamics triggering loss of proteostasis, driving neurodegeneration and clinical evolution.

pathology

A Common Trigger in Neurodegenerative and Metabolic Non-Communicable Diseases"

Vascular Function in Chronic Non-Communicable Diseases 2.0

Viral and Inflammatory Triggers of Neurodegenerative Diseases

Pathogenic or Therapeutic: The Mediating Role of Gut Microbiota in Non-Communicable Diseases

Diet, Nutrition and Chronic Degenerative Diseases

Infectious Agents and Neurodegeneration

Pathophysiology of neurodegenerative diseases: An interplay among axonal transport failure, oxidative stress, and inflammation?

Sex and Gender Differences in Neurodegenerative Diseases: Challenges for Therapeutic Opportunities

Oxidative Stress and Inflammation as Targets for Novel Preventive and Therapeutic Approaches in Non-Communicable Diseases III

Contribution of CNS and extra-CNS infections to neurodegeneration: a narrative review

A shared framework for the common mental disorders and Non-Communicable Disease: key considerations for disease prevention and control

Exploring the “Multiple-Hit Hypothesis” of Neurodegenerative Disease: Bacterial Infection Comes Up to Bat

New Insights in Neurodegenerative Diseases

Interplay among gut microbiota, intestinal mucosal barrier and enteric neuro-immune system: a common path to neurodegenerative diseases?

Overlapping Neuroimmune Mechanisms and Therapeutic Targets in Neurodegenerative Disorders

Special Issue: "Neurodegenerative Diseases: Recent Advances and Future Perspectives"

Small Non-coding RNAs: New Class of Biomarkers and Potential Therapeutic Targets in Neurodegenerative Disease

Target- and mechanism-based therapeutics for neurodegenerative diseases: strength in numbers

Exploring the Exposome Spectrum: Unveiling Endogenous and Exogenous Factors in Non-Communicable Chronic Diseases

Investigating the Interplay between Cardiovascular and Neurodegenerative Disease

The path to biomarker-based diagnostic criteria for the spectrum of neurodegenerative diseases